The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biologics Development Service Market Research Report 2024

Global Biologics Development Service Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1884735

No of Pages : 89

Synopsis
The Biologics Development Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Meso Scale Discovery
Patheon
Immunologix
GenScript
Promega
Recibiopharm
Alcami Biologics
Leadgene Biomedical
Samsung Biologics
Lonza
ImmunoGen
Seattle Genetics
Roche
Takeda
Segment by Type
Vaccine
Blood and Blood Components
Tissue and Recombinant Therapeutic Proteins
Others
Segment by Application
Tumor Treatment
Chronic Disease Treatment
Enzyme and Hormone Deficiencies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Development Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Development Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vaccine
1.2.3 Blood and Blood Components
1.2.4 Tissue and Recombinant Therapeutic Proteins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biologics Development Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tumor Treatment
1.3.3 Chronic Disease Treatment
1.3.4 Enzyme and Hormone Deficiencies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Development Service Market Perspective (2019-2030)
2.2 Biologics Development Service Growth Trends by Region
2.2.1 Global Biologics Development Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Development Service Historic Market Size by Region (2019-2024)
2.2.3 Biologics Development Service Forecasted Market Size by Region (2025-2030)
2.3 Biologics Development Service Market Dynamics
2.3.1 Biologics Development Service Industry Trends
2.3.2 Biologics Development Service Market Drivers
2.3.3 Biologics Development Service Market Challenges
2.3.4 Biologics Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Development Service Players by Revenue
3.1.1 Global Top Biologics Development Service Players by Revenue (2019-2024)
3.1.2 Global Biologics Development Service Revenue Market Share by Players (2019-2024)
3.2 Global Biologics Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Development Service Revenue
3.4 Global Biologics Development Service Market Concentration Ratio
3.4.1 Global Biologics Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Development Service Revenue in 2023
3.5 Biologics Development Service Key Players Head office and Area Served
3.6 Key Players Biologics Development Service Product Solution and Service
3.7 Date of Enter into Biologics Development Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Development Service Breakdown Data by Type
4.1 Global Biologics Development Service Historic Market Size by Type (2019-2024)
4.2 Global Biologics Development Service Forecasted Market Size by Type (2025-2030)
5 Biologics Development Service Breakdown Data by Application
5.1 Global Biologics Development Service Historic Market Size by Application (2019-2024)
5.2 Global Biologics Development Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics Development Service Market Size (2019-2030)
6.2 North America Biologics Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics Development Service Market Size by Country (2019-2024)
6.4 North America Biologics Development Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Development Service Market Size (2019-2030)
7.2 Europe Biologics Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics Development Service Market Size by Country (2019-2024)
7.4 Europe Biologics Development Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Development Service Market Size (2019-2030)
8.2 Asia-Pacific Biologics Development Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics Development Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologics Development Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Development Service Market Size (2019-2030)
9.2 Latin America Biologics Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics Development Service Market Size by Country (2019-2024)
9.4 Latin America Biologics Development Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Development Service Market Size (2019-2030)
10.2 Middle East & Africa Biologics Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics Development Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologics Development Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Meso Scale Discovery
11.1.1 Meso Scale Discovery Company Detail
11.1.2 Meso Scale Discovery Business Overview
11.1.3 Meso Scale Discovery Biologics Development Service Introduction
11.1.4 Meso Scale Discovery Revenue in Biologics Development Service Business (2019-2024)
11.1.5 Meso Scale Discovery Recent Development
11.2 Patheon
11.2.1 Patheon Company Detail
11.2.2 Patheon Business Overview
11.2.3 Patheon Biologics Development Service Introduction
11.2.4 Patheon Revenue in Biologics Development Service Business (2019-2024)
11.2.5 Patheon Recent Development
11.3 Immunologix
11.3.1 Immunologix Company Detail
11.3.2 Immunologix Business Overview
11.3.3 Immunologix Biologics Development Service Introduction
11.3.4 Immunologix Revenue in Biologics Development Service Business (2019-2024)
11.3.5 Immunologix Recent Development
11.4 GenScript
11.4.1 GenScript Company Detail
11.4.2 GenScript Business Overview
11.4.3 GenScript Biologics Development Service Introduction
11.4.4 GenScript Revenue in Biologics Development Service Business (2019-2024)
11.4.5 GenScript Recent Development
11.5 Promega
11.5.1 Promega Company Detail
11.5.2 Promega Business Overview
11.5.3 Promega Biologics Development Service Introduction
11.5.4 Promega Revenue in Biologics Development Service Business (2019-2024)
11.5.5 Promega Recent Development
11.6 Recibiopharm
11.6.1 Recibiopharm Company Detail
11.6.2 Recibiopharm Business Overview
11.6.3 Recibiopharm Biologics Development Service Introduction
11.6.4 Recibiopharm Revenue in Biologics Development Service Business (2019-2024)
11.6.5 Recibiopharm Recent Development
11.7 Alcami Biologics
11.7.1 Alcami Biologics Company Detail
11.7.2 Alcami Biologics Business Overview
11.7.3 Alcami Biologics Biologics Development Service Introduction
11.7.4 Alcami Biologics Revenue in Biologics Development Service Business (2019-2024)
11.7.5 Alcami Biologics Recent Development
11.8 Leadgene Biomedical
11.8.1 Leadgene Biomedical Company Detail
11.8.2 Leadgene Biomedical Business Overview
11.8.3 Leadgene Biomedical Biologics Development Service Introduction
11.8.4 Leadgene Biomedical Revenue in Biologics Development Service Business (2019-2024)
11.8.5 Leadgene Biomedical Recent Development
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Detail
11.9.2 Samsung Biologics Business Overview
11.9.3 Samsung Biologics Biologics Development Service Introduction
11.9.4 Samsung Biologics Revenue in Biologics Development Service Business (2019-2024)
11.9.5 Samsung Biologics Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Biologics Development Service Introduction
11.10.4 Lonza Revenue in Biologics Development Service Business (2019-2024)
11.10.5 Lonza Recent Development
11.11 ImmunoGen
11.11.1 ImmunoGen Company Detail
11.11.2 ImmunoGen Business Overview
11.11.3 ImmunoGen Biologics Development Service Introduction
11.11.4 ImmunoGen Revenue in Biologics Development Service Business (2019-2024)
11.11.5 ImmunoGen Recent Development
11.12 Seattle Genetics
11.12.1 Seattle Genetics Company Detail
11.12.2 Seattle Genetics Business Overview
11.12.3 Seattle Genetics Biologics Development Service Introduction
11.12.4 Seattle Genetics Revenue in Biologics Development Service Business (2019-2024)
11.12.5 Seattle Genetics Recent Development
11.13 Roche
11.13.1 Roche Company Detail
11.13.2 Roche Business Overview
11.13.3 Roche Biologics Development Service Introduction
11.13.4 Roche Revenue in Biologics Development Service Business (2019-2024)
11.13.5 Roche Recent Development
11.14 Takeda
11.14.1 Takeda Company Detail
11.14.2 Takeda Business Overview
11.14.3 Takeda Biologics Development Service Introduction
11.14.4 Takeda Revenue in Biologics Development Service Business (2019-2024)
11.14.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’